These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30051539)

  • 1. Lacosamide in children with drug-resistant epilepsy.
    Rüegger AD; Freeman JL; Harvey AS
    J Paediatr Child Health; 2019 Feb; 55(2):194-198. PubMed ID: 30051539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting.
    Sanmartí-Vilaplana F; Díaz-Gómez A
    Epilepsy Behav; 2018 Feb; 79():130-137. PubMed ID: 29287216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy and concomitant psychiatric conditions: Post hoc analysis of a prospective, randomized, double-blind trial.
    Schmitz B; Dimova S; Zhang Y; Chellun D; De Backer M; Gasalla T
    Epilepsy Res; 2020 Jan; 159():106220. PubMed ID: 31812127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Tolerability of Lacosamide in the Treatment of Children With Refractory Generalized Epilepsy.
    Miskin C; Khurana DS; Valencia I; Legido A; Hasbani DM; Carvalho KS
    J Child Neurol; 2016 Jun; 31(7):925-8. PubMed ID: 26887412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study.
    Toupin JF; Lortie A; Major P; Diadori P; Vanasse M; Rossignol E; D'Anjou G; Perreault S; Larbrisseau A; Carmant L; Birca A
    Epileptic Disord; 2015 Dec; 17(4):436-43. PubMed ID: 26609635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
    Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M
    Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
    Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
    Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
    Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of observational studies in supporting extrapolation of efficacy data from adults to children with epilepsy - A systematic review of the literature using lacosamide as an example.
    Arzimanoglou A; Kalilani L; Anamoo MA; Cooney M; Golembesky A; Taeter C; Bozorg A; Tofighy A; Wheless J
    Eur J Paediatr Neurol; 2019 Jul; 23(4):589-603. PubMed ID: 31171490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.
    Pasha I; Kamate M; Didagi SK
    Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide effectiveness and tolerability in patients with drug-resistant epilepsy and severe disability under polytherapy: Therapy optimization as emerging from an observational study.
    Pozzi M; Zanotta N; Epifanio R; Baldelli S; Cattaneo D; Clementi E; Zucca C
    Epilepsy Behav; 2022 Mar; 128():108598. PubMed ID: 35151192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures.
    Farkas V; Steinborn B; Flamini JR; Zhang Y; Yuen N; Borghs S; Bozorg A; Daniels T; Martin P; Carney HC; Dimova S; Scheffer IE;
    Neurology; 2019 Sep; 93(12):e1212-e1226. PubMed ID: 31462582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of add-on stiripentol treatment in children, adolescents, and young adults with refractory epilepsies: A single center prospective observational study.
    Rosati A; Boncristiano A; Doccini V; Pugi A; Pisano T; Lenge M; De Masi S; Guerrini R
    Epilepsia; 2019 Nov; 60(11):2255-2262. PubMed ID: 31630399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence status induced by lacosamide adjunctive therapy.
    Ákos Szabó C; Morgan LC; Sonnenberg S; Karkar KM
    Epileptic Disord; 2019 Feb; 21(1):97-101. PubMed ID: 30782579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies-An Italian observational multicenter study.
    De Liso P; Vigevano F; Specchio N; De Palma L; Bonanni P; Osanni E; Coppola G; Parisi P; Grosso S; Verrotti A; Spalice A; Nicita F; Zamponi N; Siliquini S; Giordano L; Martelli P; Guerrini R; Rosati A; Ilvento L; Belcastro V; Striano P; Vari MS; Capovilla G; Beccaria F; Bruni O; Luchetti A; Gobbi G; Russo A; Pruna D; Tozzi AE; Cusmai R
    Epilepsy Res; 2016 Nov; 127():93-100. PubMed ID: 27568598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel action of lacosamide on GABA
    Ruffolo G; Di Bonaventura C; Cifelli P; Roseti C; Fattouch J; Morano A; Limatola C; Aronica E; Palma E; Giallonardo AT
    Neurobiol Dis; 2018 Jul; 115():59-68. PubMed ID: 29621596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of treatment changes in patients with drug-resistant chronic epilepsy: A tertiary center experience.
    Martínez-Lizana E; Gil-Lopez F; Donaire A; Aparicio J; Brandt A; Carreño M
    Epilepsy Res; 2017 Oct; 136():97-102. PubMed ID: 28810185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.